TORTI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.392
EU - Europa 1.020
AS - Asia 843
OC - Oceania 11
AF - Africa 8
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.281
Nazione #
US - Stati Uniti d'America 2.354
CN - Cina 450
IT - Italia 256
SG - Singapore 140
IE - Irlanda 126
DE - Germania 111
SE - Svezia 83
FR - Francia 82
JP - Giappone 66
FI - Finlandia 62
AT - Austria 58
GB - Regno Unito 57
PL - Polonia 43
UA - Ucraina 41
KR - Corea 36
IN - India 31
CA - Canada 30
VN - Vietnam 27
HK - Hong Kong 24
ID - Indonesia 18
BE - Belgio 17
RU - Federazione Russa 15
TR - Turchia 13
CH - Svizzera 12
ES - Italia 11
AU - Australia 10
NL - Olanda 9
TW - Taiwan 9
DK - Danimarca 7
IR - Iran 7
MX - Messico 6
TH - Thailandia 6
RO - Romania 5
HU - Ungheria 4
SN - Senegal 4
BR - Brasile 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
IQ - Iraq 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
ZA - Sudafrica 3
BG - Bulgaria 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
IL - Israele 1
IM - Isola di Man 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 4.281
Città #
Chandler 299
Fairfield 244
Ann Arbor 190
Beijing 171
Ashburn 134
Dublin 122
Woodbridge 120
Singapore 108
Houston 106
Seattle 101
Wilmington 100
Cambridge 76
Torino 74
Dearborn 61
Villeurbanne 60
Pisa 58
Vienna 58
Nyköping 57
Fremont 39
Jacksonville 38
Warsaw 36
Santa Clara 35
Shanghai 33
Princeton 31
Columbus 30
Guangzhou 23
Medford 22
Dong Ket 21
Redwood City 20
Los Angeles 19
Nanjing 19
Tokyo 18
Brussels 16
Jakarta 16
New York 16
Boardman 15
Hong Kong 15
Turin 15
Boston 14
Milan 12
Ottawa 12
San Diego 12
Hangzhou 10
Munich 10
Helsinki 9
London 9
Norwalk 9
Shenzhen 9
Taipei 9
Changsha 8
Falls Church 8
Paris 8
Toronto 8
Zhengzhou 8
Silver Spring 7
Amsterdam 6
Duncan 6
Düsseldorf 6
Manchester 6
Rome 6
Washington 6
Wuhan 6
Zurich 6
Buffalo 5
Chengdu 5
Fuzhou 5
Genoa 5
Hefei 5
Phoenix 5
Bangkok 4
Chatsworth 4
Chongqing 4
Dallas 4
Delhi 4
Galway 4
Gurgaon 4
Jinan 4
Luni 4
Moscow 4
San Mateo 4
Seoul 4
Tehran 4
Ankara 3
Austin 3
Barcelona 3
Central 3
Chicago 3
Frankfurt am Main 3
Horana South 3
Kocaeli 3
Kolkata 3
Madison 3
Marlborough 3
Montreal 3
Mountain View 3
Nanchang 3
Piemonte 3
Qingdao 3
San Jose 3
Suzhou 3
Totale 2.962
Nome #
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 663
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 332
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 321
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 319
Only a subset of Met-activated pathways are required to sustain oncogene addiction 250
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 239
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 220
Inhibition of Src impairs the growth of met-addicted gastric tumors. 216
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 177
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 176
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils 163
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 125
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 124
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 103
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 98
Diffusion-weighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum: Improvement of diagnostic accuracy by comparing perfusion-free to perfusion-sensitive measurements of the apparent diffusion coefficient 96
MET SIGNALING REGULATES GROWTH, REPOPULATING POTENTIAL AND BASAL CELL-FATE COMMITMENT OF MAMMARY LUMINAL PROGENITORS: IMPLICATIONS FOR BASAL-LIKE BREAST CANCER. 95
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 87
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 86
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 85
Met as a potential therapeutic target in basal-like breast cancer 76
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 76
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 75
A case report of narrowing primary tracheal mucosa‑associated lymphoid tissue lymphoma: A multidisciplinary approach 64
The Role of PTEN in Myeloid Malignancies 55
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia 54
RNA sequencing analysis in primary mediastina B cell lymphoma: identification of different gene expression related to chemoresistance 19
Totale 4.394
Categoria #
all - tutte 10.448
article - articoli 0
book - libri 0
conference - conferenze 3.105
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020424 0 0 0 0 45 90 74 46 61 43 34 31
2020/2021533 37 38 43 18 37 82 76 23 43 36 38 62
2021/2022577 47 47 23 45 22 30 36 40 32 45 116 94
2022/2023773 77 74 32 83 51 171 42 60 78 16 53 36
2023/2024465 42 51 35 32 32 57 30 37 11 35 61 42
2024/2025309 16 45 48 72 128 0 0 0 0 0 0 0
Totale 4.394